TG4010 Immunotherapy Combined With First-Line Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC): Phase IIb Results of the TIME Study
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-2-s3-o12
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2014
Authors
Publisher
BMJ